true

ソリューション

BDは、医療における研究から検査、診断、治療にいたるまで、包括的かつシームレスにサポートする製品やサービスを通じ、ソリューションを提供しています

bd_our_company_hero_image_984x372.jpg
専門職
すべてのソリューションを参照
  1. New Survey Reveals Nearly 3 in 4 Canadian Women Are Delaying Their OB/GYN Exams, Increasing Risks for Cervical Cancer
    New Survey Reveals Nearly 3 in 4 Canadian Women Are Delaying Their OB/GYN Exams, Increasing Risks for Cervical Cancer
    BD announced the results of a new survey revealing that 74% of women in Canada have delayed a gynecology visit, with 83% wanting more accessible and less invasive cervical cancer testing options, including at-home self-collection for human papillomavirus (HPV) tests.
  2. Women In Canada Can Now Collect Their Own Sample At Home For Cervical Cancer Screening
    Women In Canada Can Now Collect Their Own Sample At Home For Cervical Cancer Screening
    BD announced today Health Canada approval of the BD Onclarity™ HPV Assay for human papillomavirus (HPV) testing for the use of self-collected vaginal specimens at home.
  3. Mackenzie Health launches first-of-its-kind technology in Canada designed to help reduce IV pump programming medication errors
    Mackenzie Health launches first-of-its-kind technology in Canada designed to help reduce IV pump programming medication errors
    Mackenzie Health recently launched BD Alaris™ EMR Bidirectional Interoperability, which allows for two-way information flow between an IV pump and a patient’s electronic medical record.
  4. Humber and BD seek to address health human resource challenges
    Humber and BD seek to address health human resource challenges
    Humber and BD are working together to reshape the landscape of health care workforce development and address the evolving needs of the industry along with health human resources.
  5. Statement on US FDA Safety Communication
    Statement on US FDA Safety Communication
    BD-Canada is aware of the U.S. FDA issuing Safety Communication stating concern that certain plastic syringes may not provide consistent and adequate quality or performance.
  6. Health Inequity: Tackling the Profound Impact of Chronic Kidney Disease on Indigenous Peoples
    Health Inequity: Tackling the Profound Impact of Chronic Kidney Disease on Indigenous Peoples
    The kidney care community advocates for more cost-effective treatment options, which offer a better quality of life and improved outcomes, although several obstacles hinder significant progress in improving kidney failure treatment.
  7. Health Inequity: Bold Action and Collaboration Needed to Eradicate Cervical Cancer in Canada
    Health Inequity: Bold Action and Collaboration Needed to Eradicate Cervical Cancer in Canada
    Cervical cancer is one of the few cancers that is almost completely preventable through systematic screening programs, early detection with HPV testing and vaccination. Our generation holds the incredible potential to seize the opportunity to eradicate cervical cancer within our lifetime.
  8. London’s hospitals are leading the way in clinical microbiology with a world-first installation of state-of-the-art automated laboratory technology
    London’s hospitals are leading the way in clinical microbiology with a world-first installation of state-of-the-art automated laboratory technology
    London Health Sciences Centre (LHSC) and St. Joseph’s Heath Care London (St. Joseph’s) are celebrating the installation of a Total Laboratory Automation (TLA) system within the clinical microbiology laboratory.
  9. BD Awards Educational Grant for Point of Care Testing Pilot in Alberta
    BD Awards Educational Grant for Point of Care Testing Pilot in Alberta
    The program led by 19 to Zero aims to support point-of-care testing needs beyond COVID-19 for urban and rural communities in Alberta through education and diagnosis at clinics.
  10. BD Receives Health Canada Authorization for COVID-19, Influenza A/B, RSV Combination Test
    BD Receives Health Canada Authorization for COVID-19, Influenza A/B, RSV Combination Test
    BD announced that it had received Authorization under the Interim Order from Health Canada for a new molecular diagnostic combination test for SARS-CoV-2, Influenza A and B and Respiratory Syncytial Virus (RSV) to help combat a potential “tripledemic” in the upcoming respiratory virus season.
true